InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by McDonald Damien, Chief Executive Officer. Director active across 3 companies, notably Enovis CORP. Aggregated, 13 reports have been recorded. Breakdown: 1 buy · 4 sells. Total volume traded: €776k. Activity tracked since 5 May 2021. The latest transaction was filed on 12 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to McDonald Damien
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
12,634 shares@ US$25.990.020% mcap100.0% of flowCommon stock, par value $0.001SEC:0001193125-26-224739:0
143,923 shares0Common stock, par value $0.001SEC:0001193125-26-100840:0
6,457 shares@ US$30.97100.0% of flowCommon stock, par value $0.001SEC:0000950170-25-114315:0
Canonical exit: 10 Dec 2025 (T+90)
96,296 shares0Common stock, par value $0.001SEC:0000950170-25-070898:0
2,220 shares@ US$42.5510.8% of flowOrdinary SharesSEC:0001639691-23-000041:0
3,213 shares0Ordinary SharesSEC:0001639691-23-000029:0
25,131 shares0Ordinary SharesSEC:0001639691-23-000019:0
2,220 shares@ US$54.5614.1% of flowOrdinary SharesSEC:0001639691-22-000120:0
2,784 shares@ US$81.500.0053% mcap33.8% of flowOrdinary SharesSEC:0001639691-22-000031:0
3,182 shares0Ordinary SharesSEC:0001639691-22-000027:0
5,167 shares0Ordinary SharesSEC:0001639691-22-000023:0
2,784 shares@ US$81.500.0052% mcap33.1% of flowOrdinary SharesSEC:0001639691-21-000118:0
4,450 shares0Ordinary SharesSEC:0001639691-21-000051:0
13 of 13 declarations
About McDonald Damien
Damien McDonald is the Chief Executive Officer of Enovis Corp and LivaNova PLC. He oversees the operations of these companies, which are leaders in health technology. McDonald is responsible for the overall strategy and innovation, aiming to improve patient outcomes and strengthen the company's market position.
